PIAZZA ROCCO GIOVANNI

Ruolo:

Professore associato

Settore scientifico disciplinare:

MALATTIE DEL SANGUE (MED/15)

Afferenza:

E-mail:

Telefono:

0264488059
0264488015

Stanza:

U08, Piano: P04, Stanza: 4043
Via Cadore, 48 - 20900 MONZA

U8, Piano: IV, Stanza: LABORATORIO 4.10
Via Cadore, 48 - 20900 MONZA

Magistroni, V., Mauri, M., D'Aliberti, D., Mezzatesta, C., Crespiatico, I., Nava, M., et al. (2019). De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways. HAEMATOLOGICA, 104(9), 1789-1797. Dettaglio
Angaroni, F., Graudenzi, A., Rossignolo, M., Maspero, D., Calarco, T., Piazza, R., et al. (2019). Personalized therapy design for liquid tumors via optimal control theory [Altro]. Dettaglio
Fontana, D., Mauri, M., Niro, A., Massimino, L., Bertagna, M., Zambrotta, G., et al. (2018). ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION. Intervento presentato a: XV Congress of the Italian Society of Experimental Hematology, Rimini, Italy. Dettaglio
Piazza, R., Magistroni, V., Redaelli, S., Mauri, M., Massimino, L., Sessa, A., et al. (2018). SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub. NATURE COMMUNICATIONS, 9(1), 2192. Dettaglio
Redaelli, S., Ceccon, M., Zappa, M., Sharma, G., Mastini, C., Mauri, M., et al. (2018). Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer. CANCER RESEARCH, 78(24), 6866-6880. Dettaglio

Futuri studenti